Home > Product Storage and Stability Information > Combination Products
combination
products
Xultophy® 100/3.6
(insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL
There are no studies that show the safety and efficacy of Xultophy® 100/3.6 used after expiration or when stored outside of the recommended conditions. As such, Novo Nordisk cannot guarantee the potency of Xultophy® 100/3.6 when stored outside of the recommended storage conditions.1
Recommended Storage Conditions for Xultophy® 100/3.61
Before First Use
After First Use
Refrigerated (36°F - 46°F)
Room Temperature
(59°F - 86°F)
Refrigerated
(36°F - 46°F)
Until expiration date
21 Days
21 Days
See what to do when products are exposed to freezing or other conditions.
temperature
questions &
answers
References
1. Xultophy® 100/3.6 Prescribing Information. Plainsboro, NJ: Novo Nordisk Inc.
Additional Information
Speak to a live medical representative.
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.
